Latest Sales Growth News

Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.

Reece Limited reported an 8% rise in first-quarter sales driven by network expansion, while profitability dipped due to higher costs and investments. The company also completed a $365 million share buyback, signaling confidence despite subdued market conditions.

Accent Group reported a modest 1.6% rise in FY25 owned sales to $1.46 billion and a net profit after tax of $57.7 million, while outlining ambitious FY26 plans including the launch of Sports Direct stores in Australia and New Zealand.

Accent Group Limited reported modest FY25 sales growth with a cautious FY26 outlook, unveiling a strategic partnership to expand Sports Direct stores in Australia and New Zealand.

Accent Group reports modest sales growth but margin pressures in FY26 H1, announces MySale closure and new Sports Direct store launch.

xReality Group Limited reported a robust 36% revenue increase in FY25, driven by rapid expansion of its Operator XR platform and strategic balance sheet improvements. The company’s optimistic outlook for FY26 is underpinned by new contracts, AI investments, and international distributor expansion.

Coventry Group reports a challenging FY25 with revenue slipping 1.7% and EBITDA plunging 40.9%, but early FY26 results show promising recovery driven by cost cuts and ERP system stabilisation.

Lovisa Holdings reveals robust growth with 44 net new stores and a 26.2% rise in global sales during the first 20 weeks of FY26, signaling strong momentum ahead of its Annual General Meeting.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.